SCHEMBL14748742

SCHEMBL14748742

c1ccc(-c2ccc(-c3ccc(-n4c5ccccc5c5cc(-c6ccc7c(c6)c6ccccc6n7-c6cccc(-c7cc(-c8ccccc8)cc(-c8ccccc8)n7)c6)ccc54)cc3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
ATM Q13315 1/20 0.45
PTGER4 P35408 1/20 0.37
TSPO P30536 1/20 0.36
HDAC4 P56524 1/20 0.36
CYP19A1 P11511 1/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
PDE10A Q9Y233 1/20 0.35
PTGES O14684 1/20 0.35
DHODH Q02127 1/20 0.35
NR3C1 P04150 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11998312 1.00 KDM4E (0.45) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL14748759 0.99 L3MBTL1 (0.46) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL14748751 0.99 L3MBTL1 (0.46) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL14748735 0.99 L3MBTL1 (0.46) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL14748731 0.99 L3MBTL1 (0.46) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL6375105 0.99 L3MBTL1 (0.46) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL14748752 0.99 L3MBTL1 (0.46) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL14425650 0.97 L3MBTL1 (0.45) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL14748740 0.97 KDM4E (0.44) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL16805622 0.97 L3MBTL1 (0.47) KDM4EL3MBTL1ATMPTGER4TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9543530-B2 Compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode CHEIL INDUSTRIES, INC. (KR) 2017-01-10 US disclosed
US-9543530-B2 Compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode CHEIL INDUSTRIES, INC. (KR) 2017-01-10 US disclosed
US-20150021585-A1 COMPOSITION FOR ORGANIC LIGHT-EMITTING DIODE, ORGANIC LIGHT-EMITTING LAYER INCLUDING SAME, AND ORGANIC LIGHT-EMITTING DIODE SAMSUNG SDI CO., LTD. (KR) 2015-01-22 US disclosed
US-20150021585-A1 COMPOSITION FOR ORGANIC LIGHT-EMITTING DIODE, ORGANIC LIGHT-EMITTING LAYER INCLUDING SAME, AND ORGANIC LIGHT-EMITTING DIODE SAMSUNG SDI CO., LTD. (KR) 2015-01-22 US disclosed
US-20130056720-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2013-03-07 US disclosed
US-20130056720-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2013-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130056720-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE AOX1, PPOX, OR51E2 KDM4E 2263/4885L3MBTL1 1130/4885ATM 4552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.